摘要
背景:偏头痛是一种高度致残的神经血管性原发性头痛疾病,其确切的病理机制仍未被揭示。 目前的主要假设是基于三叉神经血管系统的敏化和激活。 目的:重点研究犬尿氨酸(L-型犬尿氨酸和犬尿烯酸)和垂体腺苷酸环化酶活化多肽对三叉神经血管系统调控的影响。 方法:通过在MEDLINE / PubMed数据库中使用关键词“犬尿氨酸”,“垂体腺苷酸环化酶激活多肽”和“偏头痛”进行文献检索,以查明截至2016年9月10日临床前和临床出版物(198篇参考文献)的专题审查。 使用的其他筛选词包括“审查”,“系统评价”,“原始文章”和“英语”。 结果:L-型犬尿氨酸和犬尿烯酸对三叉神经核中二级伤害性神经元水平的谷氨酸能系统起作用。 垂体腺苷酸环化酶激活多肽从三叉神经假性神经元的周围神经末梢释放并引起血管舒张和肥大细胞脱粒,导致硬脑膜伤害感受器的周围致敏。 垂体腺苷酸环化酶激活多肽在三叉神经尾核中心释放导致二级神经元的中枢敏化。 致敏过程导致偏头痛的特征。 结论:L-型犬尿氨酸和犬尿烯酸和垂体腺苷酸环化酶活化多肽可能在最初偏头痛发作中发挥重要作用。
关键词: 谷氨酸,犬尿氨酸,偏头痛,作用方式,病理机制,垂体腺苷酸环化酶活化多肽。
Current Medicinal Chemistry
Title:Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects
Volume: 24 Issue: 13
关键词: 谷氨酸,犬尿氨酸,偏头痛,作用方式,病理机制,垂体腺苷酸环化酶活化多肽。
摘要: Background: Migraine is a highly disabling neurovascular primary headache disorder, with its exact pathomechanism being still unrevealed. The current leading hypotheses are based on the sensitization and activation of the trigeminovascular system.
Objective: To review the literature with focus on the effects of kynurenines (L-kynurenine and kynurenic acid) and pituitary adenylate cyclase-activating polypeptide on the regulation of the trigeminovascular system. Method: A literature search was conducted to identify preclinical and clinical publications (198 references) by using the keywords ‘kynurenines’, ‘pituitary adenylate cyclase-activating polypeptide’, and ‘migraine’ in the database of MEDLINE/PubMed up to 10 September 2016 for topical review. Additional filters used included ‘review’, ‘systematic review’, ‘original article’, and ‘English language’. Results: L-kynurenine and kynurenic acid act on the glutamatergic system at the level of the second-order nociceptive neurons in the trigeminal nucleus caudalis. Pituitary adenylate cyclase- activating polypeptide is released from the peripheral nerve endings of the trigeminal pseudounipolar neurons and causes vasodilation and mast cell degranulation, leading to consequent peripheral sensitization of the dural nociceptors. Centrally released pituitary adenylate cyclase-activating polypeptide in the trigeminal nucleus caudalis results in the central sensitization of the second-order neurons. The sensitization process leads to the characteristic features of migraine. Conclusion: L-kynurenine, kynurenic acid, and pituitary adenylate cyclase-activating polypeptide may have fundamental roles in the initiation of migraine headache attacks.Export Options
About this article
Cite this article as:
Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects, Current Medicinal Chemistry 2017; 24 (13) . https://dx.doi.org/10.2174/0929867324666170227115019
DOI https://dx.doi.org/10.2174/0929867324666170227115019 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design Antidepressants: Update on Benefits and Risks
Current Psychopharmacology Reposition of the Fungicide Ciclopirox for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Olanzapine vs Aripiprazole in the Management of Borderline Personality Disorder
Current Psychopharmacology The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19
Current Pharmaceutical Design ‘Non-Criteria’ Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered
CNS & Neurological Disorders - Drug Targets The Effects of Nano-curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-blind Clinical Trial Study from Gene Expression to Clinical Symptoms
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
CNS & Neurological Disorders - Drug Targets Withdrawal Notice: Evaluation of Clinical Profile, Diagnostic Tests, And Prognosis of Crypto-coccal Meningitis in HIV Infected Patients in Western India
Infectious Disorders - Drug Targets Programmed Symptoms: Disparate Effects United by Purpose
Current Rheumatology Reviews Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design
Current Pharmaceutical Design Endometriosis: The Role of Pharmacotherapy
Current Women`s Health Reviews A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus
Current Pharmaceutical Design Strategies to Convert PACAP from a Hypophysiotropic Neurohormone Into a Neuroprotective Drug
Current Pharmaceutical Design Natural Medicine:The Genus Angelica
Current Medicinal Chemistry Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza
Current Drug Targets Withdrawal Notice: Pharmacological analysis of Cannabis sativa L.: A potent herbal plant
Mini-Reviews in Medicinal Chemistry CRF Receptors as a Potential Target in the Development of Novel Pharmacotherapies for Depression
Current Pharmaceutical Design Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery